Conclusions
Invasive growth or systemic infections by A. oryzae in healthy humans have never been reported. In a few cases, however, isolates identified as A. oryzae have been recovered from debilitated patients. A. oryzae has therefore low pathogenic potential but may, like many other harmless microorganisms, grow in human tissue under exceptional circumstances. Allergic diseases primarily caused by A. oryzae have been reported in few cases, but probably presuppose both a sensitivity to allergenic reactions and a massive exposure to conidia by inhalation. A. oryzae does not produce aflatoxins or any other cancerogenic metabolites. The absence of significant levels of mycotoxins in industrial products is regularly checked. We therefore consider A. oryzae an excellent host for the safe production of harmless products by recombinant strains.
Similar content being viewed by others
References
Akiyama K, Takizawa H, Suzuki M, Miyachi S, Ichinohe M, Yanagihara Y (1987) Allergic bronchopulmonary aspergillosis due to Aspergillus oryzae. Chest 91:285–287
Atkinson C (1989) SP-400 — 13 week oral toxicity study in rats. Obtainable from Novo Nordisk, Bagsværd, Denmark
Benkhammer OF, Gaudemer I, Bouvier-Fourcade (1985) Heterokaryosis between Aspergillus oryzae cyclopiazonic acid-defective strains: method for estimating the risk of inducing toxin production among cyclopiazonic acid-defective industrial strains. Appl Environ Microbiol 50:1087–1093
Boer AS de, Diderichsen B (1991) On the safety of Bacillus subtilis and B. amyloliquefaciens. A review. Appl Microbiol Biotechnol 36:1–4
Boer AS de, Heldt-Hansen HP (1988) Genfinding af gensplejset Aspergillus oryzae i rotte faeces. Obtainable from Novo Nordisk, Bagsværd
Byard RW, Bonin RA, Haq AU (1986) Invasion of paranasal sinuses by Aspergillus oryzae. Mycopathologia 96:41–43
Christensen T, Woeldike H, Boel E, Mortensen SB, Hjortshoej K, Thim L, Hansen MT (1988) High level expression of recombinant genes in Aspergillus oryzae. Bio/Technology 6:1419–1422
Cole RJ, Cox RH (1981) Handbook of toxic fungal metabolites. Academic Press, New York
Domsch KH, Gams W, Anderson TH (1980) Compendium of soil fungi. Academic Press, New York
El-Hag N, Morse RE (1976) Aflatoxin production by a variant of Aspergillus oryzae (NRRL strain 1988) on cowpeas (Vigna sinensis). Science 192:1345–46
FAO/WHO (1988) (Food and Agriculture Organisation/World Health Organisation) Joint FAO/WHO Expert Committee on Food Additives. WHO Tech Rep Ser 759:16–17
FAO (1990) Food and Nutritional Paper no. 49. Specification for identity and purity of certain food additives
FCC (1981) Food Chemical Codex, 3rd edn. National Academy Press, Washington
Fennell DL (1976) Aspergillus oryzae (NRRL strain 1988): a clarification. Science 194:1188
Gordon MA, Holzman RS (1976) Aspergillus oryzae meningitis. J Am Med Ass 235:2122–2123
Hermansen K, Frisvad JC, Emborg C, Hansen J (1984) Cyclopiazonic acid production by submerged cultures of Penicillium and Aspergillus strains. FEMS Microbiol Lett 21:253–261
Huge-Jensen B, Andreasen F, Christensen T, Christensen M, Thim L, Boel E (1989) Rhizomucor miehei triglyceride lipase is processed and secreted from transformed Aspergillus oryzae. Lipids 24:781–785
Iwasaki T, Kosikowski FV (1973) Production of beta-nitropropionic acid in foods. J Food Sci 38:1162–1165
Kino T, Chihara J, Mitsuyasu K, et al. (1982) A case of allergic bronchopulmonary aspergillosis caused by Aspergillus oryzae which is used for brewing bean paste (miso) and soy sauce (shoyu). Jpn J Thorac Dis 20:467–475
Kinosita R, Ishiko T, Sugiyama S, Seto T, Igarasi S, Goetz IE (1968) Mycotoxins in fermented foods. Cancer Res 28:2296–2311
Klich MA, Pitt JI (1988) Differentiation of Aspergillus flavus from A. parasiticus and other closely related species. Trans Br Mycol Soc 91:99–108
Kobayashi O, Narita M, Kawamoto H, et al. (1984) A case of broncho-pulmonary aspergillosis due to A. oryzae and its subtype. Jpn J Thorac Dis 22:925–931
Kozakiewicz Z (1989) Aspergillus species on stored products. Mycological Papers, No. 161, CAB International Mycological Institute, Kew
Kurosawa M, Kobayashi S, Yanagihara Y, Shida T (1990) A case of occupational allergic bronchopulmonary aspergillosis unique to Japan. Br J Clin Pract 44:482–489
Liao WQ, Shao JZ, Li SQ, et al. (1988) Mycological identification of pulmonary aspergilloma caused by Aspergillus oryzae with proliferating heads. Chin Med J 101:601–604
Liljegren K, Svendsen A, Frisvad JC (1988) Mycotoxin and exoenzyme production by members of Aspergillus section Flavi: an integrated taxonomic approach to their classification. Proc Jpn Mycotoxicol. Suppl. no. 1:35–36
Manabe M, Tanaka K, Goto T, Matsuura S (1984) Producing capability of kojic acid and aflatoxin by kojic mold. In: Kurata H, Ueno Y (eds) Toxigenic fungi — their toxins and health Hasard. Elsevier, Amsterdam, pp 4–14
OECD (1986) (Organisation for Economic Co-operation and Development) Recombinant DNA safety considerations
Orth R (1977) Mycotoxins of Aspergillus oryzae strains for use in the food industry as starters and enzyme producing molds. Ann Nutr Aliment 31:617–624
Raper KB, Fennell DI (1965) The genus Aspergillus. Williams and Wilkins, Baltimore
Samson RA (1985) Taxonomic considerations of harmful and beneficial moulds in food. In: Arai T (ed) Filamentous microorganisms, biomedical aspects. Japan Scientific Societies Press, Toyko, pp 157–163
Samson RA, Pitt JI (1985) Advances in Penicillium and Aspergillus systematics. Plenum Press, New York
Samson RA, Pitt JI (1990) Modern concepts in Penicillium and Aspergillus classification. Plenum Press, New York
Sawasaki H, Horie K, Yamada M, et al. (1969) Bronchial stump aspergillosis. Experimental and clinical study. J Thorac Cardiovasc Surg 58:198–208
Stavsbjerg M (1988) Study on the relative pathogenicity of two strains of the fungus Aspergillus oryzae by intravenous administration to mice. Obtainable from Novo Nordisk, Bagsværd
Stelmaska E, Pietkiewicz D, Dabrowski W (1974) Aspergillosis of the external ear. Pol Tyg Lek 29:2039–2040
Stenson S, Brookner A, Rosenthal S (1982) Bilateral endogeneous necrotizing scleritis due to Aspergillus oryzae. Ann Ophthalmol 14:67–72
Stoloff L, Mislivic A, Schindler F (1977) Aspergillus oryzae (NRRL strain 1988). Science 196:1353–54
Tanizaki K, Takahashi K, Hosokawa M, et al. (1979) Immunological investigation of bronchopulmonary aspergillosis. A case where Aspergillus oryzae is suspected as the cause. Jpn J Thorac Dis 17:686–691
Tochigi T, Saeki H, Yamashita S, et al. (1988) A case of allergic bronchopulmonary aspergillosis caused by Aspergillus oryzae and A. fumigatus. Jpn J Chest Dis 47:172–177
Tomizawa T (1980) Mycosis of the external auditory meatus. Asian Med J 23:295–298
Wicklow DT (1984) Adaptation in wild and domesticated yellow-green aspergilli. In: Kurata H, Ueno Y (eds) Toxigenic fungi —their toxins and health hazard. Elsevier, Amsterdam, pp 78–86
Ziskind J, Pizzolato P, Buff EE (1958) Aspergillosis of the brain. Report of a case. Am J Clin Pathol 29:554–559
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barbesgaard, P., Heldt-Hansen, H.P. & Diderichsen, B. On the safety of Aspergillus oryzae: a review. Appl Microbiol Biotechnol 36, 569–572 (1992). https://doi.org/10.1007/BF00183230
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00183230